共 50 条
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey
被引:0
|作者:
Pascal Richette
Laura C. Coates
Valderilio F. Azevedo
Joseph C. Cappelleri
Jade Moser
Ruben Queiro-Silva
Lara Fallon
Meriem Kessouri
机构:
[1] University of Paris,Rheumatology Department, Lariboisière Hospital, Lariboisière
[2] University of Oxford,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[3] Universidade Federal do Paraná,Rheumatology Division
[4] Pfizer Inc,undefined
[5] The Harris Poll,undefined
[6] Hospital Universitario Central de Asturias (HUCA),undefined
[7] Pfizer Canada,undefined
[8] Pfizer France,undefined
来源:
关键词:
Patients’ satisfaction;
Perception;
Preference;
Psoriatic arthritis treatment;
Psoriatic arthritis;
Surveys and questionnaires;
Real-world evidence;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Psoriatic arthritis (PsA) is a disease that can cause joint pain and stiffness, and is often associated with a skin rash called psoriasis. These symptoms can affect quality of life, and patients and doctors should work together when choosing treatment. There has not been a lot of information on what patients think about their disease and their medicines. We found that patients from different regions and countries had different opinions, and that treatment of PsA can be improved. For example, patients in North America were more likely to say that their overall health was excellent or good, compared with patients in Europe. However, more patients in North America than in Europe described their PsA disease as severe. Similar numbers of patients in both regions experienced impacts on their social life due to their PsA, but patients in Europe were more likely to report that PsA affected their work life compared with patients in North America. More patients in North America than in Europe were satisfied with their medicines, but patients across all regions and countries still had symptoms even when they took medicines. Many patients also wished they had more options and wanted to change something about their medicines. These findings were based on an online survey. Patients from North America (Canada and the US) and Europe (France, Spain, and the UK) answered questions about their PsA disease and medicines. We only compared answers between patients from North America and Europe, and between countries within each region.
引用
收藏
页码:823 / 838
页数:15
相关论文